Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the complete record of transactions filed by Bisaro Paul, Director. Director active across 5 companies, notably Zoetis Inc.. Aggregated, 25 filings have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €226k. Activity tracked since 16 August 2021. The latest transaction was disclosed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bisaro Paul
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Bisaro Paul is a Director at Zoetis Inc., Myriad Genetics INC, Mallinckrodt plc, Keenova Therapeutics plc and TherapeuticsMD, Inc. The record shows 25 filings in total, and across the 25 sampled filings, buys amount to EUR 226221, sells to EUR 0, with a date range from 2021-08-12 to 2026-06-05, and the most common transaction nature being option exercise.